Pentostatin, cyclophosphamide, and ritux
β
Tait D. Shanafelt; Thomas Lin; Susan M. Geyer; Clive S. Zent; Nelson Leung; Bria
π
Article
π
2007
π
John Wiley and Sons
π
English
β 142 KB
π 1 views
## Abstract ## BACKGROUND. The prevalence of chronic lymphocytic leukemia (CLL) increases with age. Although chemoimmunotherapy (CIT) has dramatically improved response rates in patients with CLL, some CIT regimens are not well tolerated by many patients β₯70 years of age. ## METHODS. Sixtyβfour